Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. NVDA
3. SPCX
4. MU
5. LCO
6. KR
7. APGE
8. MSTR
9. ABBV
10. DFTX

Go back to Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 2.98 +0.10 (3.47%)
Previous Close $2.88    52 Week High $9.58 
Open $3.01    52 Week Low $2.34 
Day High $3.01    P/E N/A 
Day Low $2.94    EPS $-0.34 
Volume 115,408